_version_ 1785045683189841920
author Bahri, Priya
Bowring, Geoffrey
Edwards, Brian D.
Anton, Christopher
Aronson, Jeffrey K.
Caro-Rojas, Angela
Hugman, Bruce P. J.
Mol, Peter G.
Trifirò, Gianluca
Ilic, Katarina
Daghfous, Riadh
Fermont, Irene
Furlan, Giovanni
Gaissmaier, Wolfgang
Geer, Mohammad Ishaq
Hartigan-Go, Kenneth Y.
Houÿez, François
Neth, Hansjörg
Norgela, Gediminas
Oppamayun, Yaowares
Raynor, D. K. Theo
Bouhlel, Mehdi
Santoro, Federica
Sultana, Janet
author_facet Bahri, Priya
Bowring, Geoffrey
Edwards, Brian D.
Anton, Christopher
Aronson, Jeffrey K.
Caro-Rojas, Angela
Hugman, Bruce P. J.
Mol, Peter G.
Trifirò, Gianluca
Ilic, Katarina
Daghfous, Riadh
Fermont, Irene
Furlan, Giovanni
Gaissmaier, Wolfgang
Geer, Mohammad Ishaq
Hartigan-Go, Kenneth Y.
Houÿez, François
Neth, Hansjörg
Norgela, Gediminas
Oppamayun, Yaowares
Raynor, D. K. Theo
Bouhlel, Mehdi
Santoro, Federica
Sultana, Janet
author_sort Bahri, Priya
collection PubMed
description
format Online
Article
Text
id pubmed-10203670
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-102036702023-05-25 Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance Bahri, Priya Bowring, Geoffrey Edwards, Brian D. Anton, Christopher Aronson, Jeffrey K. Caro-Rojas, Angela Hugman, Bruce P. J. Mol, Peter G. Trifirò, Gianluca Ilic, Katarina Daghfous, Riadh Fermont, Irene Furlan, Giovanni Gaissmaier, Wolfgang Geer, Mohammad Ishaq Hartigan-Go, Kenneth Y. Houÿez, François Neth, Hansjörg Norgela, Gediminas Oppamayun, Yaowares Raynor, D. K. Theo Bouhlel, Mehdi Santoro, Federica Sultana, Janet Drug Saf FROM THE ISoP Springer International Publishing 2023-05-23 2023 /pmc/articles/PMC10203670/ /pubmed/37219785 http://dx.doi.org/10.1007/s40264-023-01285-5 Text en © The Author(s), under exclusive licence to Springer Nature Switzerland AG 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle FROM THE ISoP
Bahri, Priya
Bowring, Geoffrey
Edwards, Brian D.
Anton, Christopher
Aronson, Jeffrey K.
Caro-Rojas, Angela
Hugman, Bruce P. J.
Mol, Peter G.
Trifirò, Gianluca
Ilic, Katarina
Daghfous, Riadh
Fermont, Irene
Furlan, Giovanni
Gaissmaier, Wolfgang
Geer, Mohammad Ishaq
Hartigan-Go, Kenneth Y.
Houÿez, François
Neth, Hansjörg
Norgela, Gediminas
Oppamayun, Yaowares
Raynor, D. K. Theo
Bouhlel, Mehdi
Santoro, Federica
Sultana, Janet
Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance
title Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance
title_full Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance
title_fullStr Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance
title_full_unstemmed Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance
title_short Communicating for the Safe Use of Medicines: Progress and Directions for the 2020s Promoted by the Special Interest Group of the International Society of Pharmacovigilance
title_sort communicating for the safe use of medicines: progress and directions for the 2020s promoted by the special interest group of the international society of pharmacovigilance
topic FROM THE ISoP
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10203670/
https://www.ncbi.nlm.nih.gov/pubmed/37219785
http://dx.doi.org/10.1007/s40264-023-01285-5
work_keys_str_mv AT bahripriya communicatingforthesafeuseofmedicinesprogressanddirectionsforthe2020spromotedbythespecialinterestgroupoftheinternationalsocietyofpharmacovigilance
AT bowringgeoffrey communicatingforthesafeuseofmedicinesprogressanddirectionsforthe2020spromotedbythespecialinterestgroupoftheinternationalsocietyofpharmacovigilance
AT edwardsbriand communicatingforthesafeuseofmedicinesprogressanddirectionsforthe2020spromotedbythespecialinterestgroupoftheinternationalsocietyofpharmacovigilance
AT antonchristopher communicatingforthesafeuseofmedicinesprogressanddirectionsforthe2020spromotedbythespecialinterestgroupoftheinternationalsocietyofpharmacovigilance
AT aronsonjeffreyk communicatingforthesafeuseofmedicinesprogressanddirectionsforthe2020spromotedbythespecialinterestgroupoftheinternationalsocietyofpharmacovigilance
AT carorojasangela communicatingforthesafeuseofmedicinesprogressanddirectionsforthe2020spromotedbythespecialinterestgroupoftheinternationalsocietyofpharmacovigilance
AT hugmanbrucepj communicatingforthesafeuseofmedicinesprogressanddirectionsforthe2020spromotedbythespecialinterestgroupoftheinternationalsocietyofpharmacovigilance
AT molpeterg communicatingforthesafeuseofmedicinesprogressanddirectionsforthe2020spromotedbythespecialinterestgroupoftheinternationalsocietyofpharmacovigilance
AT trifirogianluca communicatingforthesafeuseofmedicinesprogressanddirectionsforthe2020spromotedbythespecialinterestgroupoftheinternationalsocietyofpharmacovigilance
AT ilickatarina communicatingforthesafeuseofmedicinesprogressanddirectionsforthe2020spromotedbythespecialinterestgroupoftheinternationalsocietyofpharmacovigilance
AT daghfousriadh communicatingforthesafeuseofmedicinesprogressanddirectionsforthe2020spromotedbythespecialinterestgroupoftheinternationalsocietyofpharmacovigilance
AT fermontirene communicatingforthesafeuseofmedicinesprogressanddirectionsforthe2020spromotedbythespecialinterestgroupoftheinternationalsocietyofpharmacovigilance
AT furlangiovanni communicatingforthesafeuseofmedicinesprogressanddirectionsforthe2020spromotedbythespecialinterestgroupoftheinternationalsocietyofpharmacovigilance
AT gaissmaierwolfgang communicatingforthesafeuseofmedicinesprogressanddirectionsforthe2020spromotedbythespecialinterestgroupoftheinternationalsocietyofpharmacovigilance
AT geermohammadishaq communicatingforthesafeuseofmedicinesprogressanddirectionsforthe2020spromotedbythespecialinterestgroupoftheinternationalsocietyofpharmacovigilance
AT hartigangokennethy communicatingforthesafeuseofmedicinesprogressanddirectionsforthe2020spromotedbythespecialinterestgroupoftheinternationalsocietyofpharmacovigilance
AT houyezfrancois communicatingforthesafeuseofmedicinesprogressanddirectionsforthe2020spromotedbythespecialinterestgroupoftheinternationalsocietyofpharmacovigilance
AT nethhansjorg communicatingforthesafeuseofmedicinesprogressanddirectionsforthe2020spromotedbythespecialinterestgroupoftheinternationalsocietyofpharmacovigilance
AT norgelagediminas communicatingforthesafeuseofmedicinesprogressanddirectionsforthe2020spromotedbythespecialinterestgroupoftheinternationalsocietyofpharmacovigilance
AT oppamayunyaowares communicatingforthesafeuseofmedicinesprogressanddirectionsforthe2020spromotedbythespecialinterestgroupoftheinternationalsocietyofpharmacovigilance
AT raynordktheo communicatingforthesafeuseofmedicinesprogressanddirectionsforthe2020spromotedbythespecialinterestgroupoftheinternationalsocietyofpharmacovigilance
AT bouhlelmehdi communicatingforthesafeuseofmedicinesprogressanddirectionsforthe2020spromotedbythespecialinterestgroupoftheinternationalsocietyofpharmacovigilance
AT santorofederica communicatingforthesafeuseofmedicinesprogressanddirectionsforthe2020spromotedbythespecialinterestgroupoftheinternationalsocietyofpharmacovigilance
AT sultanajanet communicatingforthesafeuseofmedicinesprogressanddirectionsforthe2020spromotedbythespecialinterestgroupoftheinternationalsocietyofpharmacovigilance